Table of Content
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Drug Delivery Technologies Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Rising Prevalence of Chronic Diseases
3.2.1.2 Technological Advancements Driving Industry Growth
3.2.1.3 Rising Focus on Patient-centric Care
3.2.1.4 Integration of AI and Big Data
3.2.2 Market Restraining Factors
3.2.2.1 Lack of Awareness and Infrastructure
3.2.2.2 Risk of Needlestick Injuries
3.2.2.3 Reimbursement Issues in Advanced Drug Delivery Technologies
3.2.3 Market Opportunities
3.2.3.1 Self-administration and Home Care
3.2.3.2 Digital Integration and Connectivity
3.2.3.3 Expanding Applications in Biologics and Gene Therapies
3.2.3.4 Sustainable and Eco-friendly Innovations in Drug Delivery Technologies
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat of Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Drug Delivery Technologies Market Analysis by Route of Administration
4.1 Key Findings
4.2 Route of Administration Segment: Market Attractiveness Index
4.3 Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
4.4 Implantable Drug Delivery
4.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Injectable Drug Delivery
4.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Nasal Drug Delivery
4.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Ocular Drug Delivery
4.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.7.2 Market Share by Region, 2024 & 2034 (%)
4.8 Oral Drug Delivery
4.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.8.2 Market Share by Region, 2024 & 2034 (%)
4.9 Pulmonary Drug Delivery
4.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.9.2 Market Share by Region, 2024 & 2034 (%)
4.10 Topical Drug Delivery
4.10.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.10.2 Market Share by Region, 2024 & 2034 (%)
4.11 Transmucosal Drug Delivery
4.11.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
4.11.2 Market Share by Region, 2024 & 2034 (%)
5 Drug Delivery Technologies Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Drug Delivery Technologies Market Size Estimation and Forecast by Application
5.4 Cancer
5.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Cardiovascular
5.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Diabetes
5.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
5.6.2 Market Share by Region, 2024 & 2034 (%)
5.7 Infectious Diseases
5.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
5.7.2 Market Share by Region, 2024 & 2034 (%)
5.8 Others
5.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
5.8.2 Market Share by Region, 2024 & 2034 (%)
6 Drug Delivery Technologies Market Analysis by End-users
6.1 Key Findings
6.2 End-users Segment: Market Attractiveness Index
6.3 Drug Delivery Technologies Market Size Estimation and Forecast by End-users
6.4 Ambulatory Surgical Centres
6.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
6.4.2 Market Share by Region, 2024 & 2034 (%)
6.5 Hospitals
6.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
6.5.2 Market Share by Region, 2024 & 2034 (%)
6.6 Home Care Settings
6.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
6.6.2 Market Share by Region, 2024 & 2034 (%)
6.7 Others
6.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
6.7.2 Market Share by Region, 2024 & 2034 (%)
7 Drug Delivery Technologies Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast
8 North America Drug Delivery Technologies Market Analysis
8.1 Key Findings
8.2 North America Drug Delivery Technologies Market Attractiveness Index
8.3 North America Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
8.4 North America Drug Delivery Technologies Market Size Estimation and Forecast by Country
8.5 North America Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
8.6 North America Drug Delivery Technologies Market Size Estimation and Forecast by Application
8.7 North America Drug Delivery Technologies Market Size Estimation and Forecast by End-users
8.8 U.S. Drug Delivery Technologies Market Analysis
8.9 Canada Drug Delivery Technologies Market Analysis
9 Europe Drug Delivery Technologies Market Analysis
9.1 Key Findings
9.2 Europe Drug Delivery Technologies Market Attractiveness Index
9.3 Europe Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
9.4 Europe Drug Delivery Technologies Market Size Estimation and Forecast by Country
9.5 Europe Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
9.6 Europe Drug Delivery Technologies Market Size Estimation and Forecast by Application
9.7 Europe Drug Delivery Technologies Market Size Estimation and Forecast by End-users
9.8 Germany Drug Delivery Technologies Market Analysis
9.9 UK Drug Delivery Technologies Market Analysis
9.10 France Drug Delivery Technologies Market Analysis
9.11 Italy Drug Delivery Technologies Market Analysis
9.12 Spain Drug Delivery Technologies Market Analysis
9.13 Russia Drug Delivery Technologies Market Analysis
9.14 Rest of Europe Drug Delivery Technologies Market Analysis
10 Asia Pacific Drug Delivery Technologies Market Analysis
10.1 Key Findings
10.2 Asia Pacific Drug Delivery Technologies Market Attractiveness Index
10.3 Asia Pacific Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
10.4 Asia Pacific Drug Delivery Technologies Market Size Estimation and Forecast by Country
10.5 Asia Pacific Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
10.6 Asia Pacific Drug Delivery Technologies Market Size Estimation and Forecast by Application
10.7 Asia Pacific Drug Delivery Technologies Market Size Estimation and Forecast by End-users
10.8 Japan Drug Delivery Technologies Market Analysis
10.9 China Drug Delivery Technologies Market Analysis
10.10 India Drug Delivery Technologies Market Analysis
10.11 Australia Drug Delivery Technologies Market Analysis
10.12 South Korea Drug Delivery Technologies Market Analysis
10.13 South-East Asia Drug Delivery Technologies Market Analysis
10.14 Rest of Asia Pacific Drug Delivery Technologies Market Analysis
11 Latin America Drug Delivery Technologies Market Analysis
11.1 Key Findings
11.2 Latin America Drug Delivery Technologies Market Attractiveness Index
11.3 Latin America Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
11.4 Latin America Drug Delivery Technologies Market Size Estimation and Forecast by Country
11.5 Latin America Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
11.6 Latin America Drug Delivery Technologies Market Size Estimation and Forecast by Application
11.7 Latin America Drug Delivery Technologies Market Size Estimation and Forecast by End-users
11.8 Brazil Drug Delivery Technologies Market Analysis
11.9 Mexico Drug Delivery Technologies Market Analysis
11.10 Rest of Latin America Drug Delivery Technologies Market Analysis
12 MEA Drug Delivery Technologies Market Analysis
12.1 Key Findings
12.2 MEA Drug Delivery Technologies Market Attractiveness Index
12.3 MEA Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
12.4 MEA Drug Delivery Technologies Market Size Estimation and Forecast by Country
12.5 MEA Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
12.6 MEA Drug Delivery Technologies Market Size Estimation and Forecast by Application
12.7 MEA Drug Delivery Technologies Market Size Estimation and Forecast by End-users
12.8 GCC Drug Delivery Technologies Market Analysis
12.9 South Africa Drug Delivery Technologies Market Analysis
12.10 Rest of MEA Drug Delivery Technologies Market Analysis
13 Company Profiles
13.1 Johnson & Johnson Services, Inc.
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis
13.1.3.1 Net Revenue, 2015-2023
13.1.3.2 Regional Market Shares, 2023
13.1.3.3 R&D, 2015-2023
13.1.4 Product Benchmarking
13.2 Novartis AG
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.3.1 Net Revenue, 2015-2023
13.2.3.2 Regional Market Shares, 2023
13.2.3.3 R&D, 2015-2023
13.2.4 Product Benchmarking
13.2.5 Strategic Outlook
13.3 F. Hoffmann-La Roche Ltd.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2015-2023
13.3.3.2 Regional Market Shares, 2023
13.3.3.3 R&D, 2015-2023
13.3.4 Product Benchmarking
13.3.5 Strategic Outlook
13.4 Pfizer Inc.
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2015-2023
13.4.3.2 Regional Market Shares, 2023
13.4.3.3 R&D, 2015-2023
13.4.4 Product Benchmarking
13.4.5 Strategic Outlook
13.5 Bayer AG
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2015-2022
13.5.3.2 Regional Market Shares, 2022
13.5.3.3 R&D, 2015-2022
13.5.4 Product Benchmarking
13.5.5 Strategic Outlook
13.6 Becton, Dickinson and Company
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2015-2023
13.6.3.2 Regional Market Shares, 2023
13.6.3.3 R&D, 2015-2023
13.6.4 Product Benchmarking
13.6.5 Strategic Outlook
13.7 GSK plc
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2015-2023
13.7.3.2 Regional Market Shares, 2023
13.7.3.3 R&D, 2015-2023
13.7.4 Product Benchmarking
13.8 Merck & Co., Inc.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2015-2023
13.8.3.2 Regional Market Shares, 2023
13.8.3.3 R&D, 2015-2023
13.8.4 Product Benchmarking
13.8.5 Strategic Outlook
13.9 Sanofi
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2015-2023
13.9.3.2 Regional Market Shares, 2023
13.9.3.3 R&D, 2015-2023
13.9.4 Product Benchmarking
13.9.5 Strategic Outlook
13.10 Amgen Inc.
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2015-2023
13.10.3.2 R&D, 2015-2023
13.10.3.3 Regional Market Shares, 2023
13.10.4 Product Benchmarking
13.10.5 Strategic Outlook
13.11 AbbVie Inc.
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2015-2023
13.11.3.2 Regional Market Shares, 2023
13.11.3.3 R&D, 2015-2023
13.11.4 Product Benchmarking
13.11.5 Strategic Outlook
13.12 Gilead Sciences, Inc.
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis
13.12.3.1 Net Revenue, 2015-2023
13.12.3.2 R&D, 2015-2023
13.12.4 Product Benchmarking
13.12.5 Strategic Outlook
13.13 Boehringer Ingelheim
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis
13.13.3.1 Net Revenue, 2015-2022
13.13.3.2 Regional Market Shares, 2022
13.13.4 Product Benchmarking
13.14 AstraZeneca plc
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.3.1 Net Revenue, 2015-2023
13.14.3.2 Regional Market Shares, 2023
13.14.3.3 R&D, 2015-2022
13.14.4 Product Benchmarking
13.14.5 Strategic Outlook
13.15 Eli Lilly and Company
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Analysis
13.15.3.1 Net Revenue, 2015-2022
13.15.3.2 Regional Market Shares, 2023
13.15.3.3 R&D, 2015-2022
13.15.4 Product Benchmarking
13.15.5 Strategic Outlook
13.16 Teva Pharmaceuticals Industries Ltd.
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Financial Analysis
13.16.3.1 Net Revenue, 2015-2022
13.16.3.2 Regional Market Shares, 2023
13.16.3.3 R&D, 2015-2022
13.16.4 Product Benchmarking
13.16.5 Strategic Outlook
13.17 Bristol-Myers Squibb
13.17.1 Company Snapshot
13.17.2 Company Overview
13.17.3 Financial Analysis
13.17.3.1 Net Revenue, 2015-2022
13.17.3.2 Regional Market Shares, 2023
13.17.3.3 R&D, 2015-2022
13.17.4 Product Benchmarking
13.18 Gerresheimer AG
13.18.1 Company Snapshot
13.18.2 Company Overview
13.18.3 Financial Analysis
13.18.3.1 Net Revenue, 2015-2023
13.18.3.2 Regional Market Shares, 2023
13.18.4 Product Benchmarking
13.18.5 Strategic Outlook
13.19 Boston Scientific Corporation
13.19.1 Company Snapshot
13.19.2 Company Overview
13.19.3 Financial Analysis
13.19.3.1 Net Revenue, 2015-2022
13.19.3.2 Regional Market Shares, 2023
13.19.3.3 R&D, 2015-2022
13.19.4 Product Benchmarking
13.19.5 Strategic Outlook
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
List of Tables
Table 1 Drug Delivery Technologies Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 Drug Delivery Technologies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Drug Delivery Technologies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Drug Delivery Technologies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Drug Delivery Technologies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 7 Implantable Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 8 Injectable Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 9 Nasal Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 10 Ocular Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 11 Oral Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 12 Pulmonary Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 13 Topical Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 14 Transmucosal Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 15 Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 16 Cancer Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 17 Cardiovascular Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 18 Diabetes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 19 Infectious Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 20 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 21 Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 22 Ambulatory Surgical Centres Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 23 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 24 Home Care Settings Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 25 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 26 Drug Delivery Technologies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 27 North America Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 28 North America Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 29 North America Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 30 North America Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 31 U.S. Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 32 Canada Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 33 Europe Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 34 Europe Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 35 Europe Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 36 Europe Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 37 Germany Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 38 UK Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 39 France Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 40 Italy Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 41 Spain Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 42 Russia Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 43 Rest of Europe Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 44 Asia Pacific Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 45 Asia Pacific Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 46 Asia Pacific Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 47 Asia Pacific Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 48 Japan Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 49 China Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 50 India Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 51 Australia Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 52 South Korea Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 53 South-East Asia Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 54 Rest of Asia Pacific Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 55 Latin America Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 56 Latin America Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 57 Latin America Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 58 Latin America Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 59 Brazil Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 60 Mexico Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 61 Rest of Latin America Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 62 MEA Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 63 MEA Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 64 MEA Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 65 MEA Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 66 GCC Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 67 South Africa Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 68 Rest of MEA Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 69 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 70 Johnson & Johnson Services, Inc.: Product Benchmarking
Table 71 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 Novartis AG: Product Benchmarking
Table 73 Novartis AG: Strategic Outlook
Table 74 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 75 F. Hoffmann-La Roche Ltd: Product Benchmarking
Table 76 F. Hoffmann-La Roche Ltd: Strategic Outlook
Table 77 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 78 Pfizer Inc.: Product Benchmarking
Table 79 Pfizer Inc.: Strategic Outlook
Table 80 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Bayer AG: Product Benchmarking
Table 82 Bayer AG: Strategic Outlook
Table 83 Becton, Dickinson and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Becton, Dickinson and Company: Product Benchmarking
Table 85 Becton, Dickinson and Company: Strategic Outlook
Table 86 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 GSK plc: Product Benchmarking
Table 88 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Merck & Co., Inc.: Product Benchmarking
Table 90 Merck & Co., Inc.: Strategic Outlook
Table 91 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Sanofi: Product Benchmarking
Table 93 Sanofi: Strategic Outlook
Table 94 Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Amgen Inc.: Product Benchmarking
Table 96 Amgen Inc.: Strategic Outlook
Table 97 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 AbbVie Inc.: Product Benchmarking
Table 99 AbbVie Inc.: Strategic Outlook
Table 100 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Gilead Sciences, Inc.: Product Benchmarking
Table 102 Gilead Sciences, Inc.: Strategic Outlook
Table 103 Boehringer Ingelheim: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Boehringer Ingelheim: Product Benchmarking
Table 105 AstraZeneca plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 AstraZeneca plc: Product Benchmarking
Table 107 AstraZeneca plc: Strategic Outlook
Table 108 Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Eli Lilly and Company: Product Benchmarking
Table 110 Eli Lilly and Company: Strategic Outlook
Table 111 Teva Pharmaceuticals Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Teva Pharmaceuticals Industries Ltd.: Product Benchmarking
Table 113 Teva Pharmaceuticals Industries Ltd.: Strategic Outlook
Table 114 Bristol-Myers Squibb: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 115 Bristol-Myers Squibb: Product Benchmarking
Table 116 Gerresheimer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 Gerresheimer AG: Product Benchmarking
Table 118 Gerresheimer AG: Strategic Outlook
Table 119 Boston Scientific Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 Boston Scientific Corporation: Product Benchmarking
Table 121 Boston Scientific Corporation: Strategic Outlook
List of Figures
Figure 1 Drug Delivery Technologies Market Segmentation
Figure 2 Drug Delivery Technologies Market by Route of Administration: Market Attractiveness Index
Figure 3 Drug Delivery Technologies Market by Application: Market Attractiveness Index
Figure 4 Drug Delivery Technologies Market by End-users: Market Attractiveness Index
Figure 5 Drug Delivery Technologies Market Attractiveness Index by Region
Figure 6 Drug Delivery Technologies Market: Market Dynamics
Figure 7 Drug Delivery Technologies Market by Region, 2024-2034 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 8 Drug Delivery Technologies Market by Region, 2024-2034 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 9 Drug Delivery Technologies Market by Region, 2024-2034 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 10 Drug Delivery Technologies Market by Region, 2024-2034 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 11 Drug Delivery Technologies Market: Porter’s Five Forces Analysis
Figure 12 Drug Delivery Technologies Market: PEST Analysis
Figure 13 Drug Delivery Technologies Market Attractiveness Index by Route of Administration
Figure 14 Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR %)
Figure 15 Drug Delivery Technologies Market Share Forecast by Route of Administration, 2024, 2029, 2034 (%)
Figure 16 Implantable Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 17 Implantable Drug Delivery Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 18 Injectable Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 19 Injectable Drug Delivery Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 20 Nasal Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 21 Nasal Drug Delivery Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 22 Ocular Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 23 Ocular Drug Delivery Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 24 Oral Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 25 Oral Drug Delivery Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 26 Pulmonary Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 27 Pulmonary Drug Delivery Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 28 Topical Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 29 Topical Drug Delivery Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 30 Transmucosal Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 31 Transmucosal Drug Delivery Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 32 Drug Delivery Technologies Market Attractiveness Index by Route of Administration
Figure 33 Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 34 Drug Delivery Technologies Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 35 Cancer Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 36 Cancer Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 37 Cardiovascular Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 38 Cardiovascular Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 39 Diabetes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 40 Diabetes Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 41 Infectious Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 42 Infectious Diseases Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 43 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 44 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 45 Drug Delivery Technologies Market Attractiveness Index by End-users
Figure 46 Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 47 Drug Delivery Technologies Market Share Forecast by End-users, 2024, 2029, 2034 (%)
Figure 48 Ambulatory Surgical Centres Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 49 Ambulatory Surgical Centres Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 50 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 51 Hospitals Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 52 Home Care Settings Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 53 Home Care Settings Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 54 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 55 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 56 Drug Delivery Technologies Market Forecast by Region 2024, 2029, 2034 (Revenue, CAGR%)
Figure 57 Drug Delivery Technologies Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 58 Drug Delivery Technologies Market by Region, 2024-2034 (US$ Bn, AGR %)
Figure 59 North America Drug Delivery Technologies Market Attractiveness Index
Figure 60 North America Drug Delivery Technologies Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 61 North America Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 62 North America Drug Delivery Technologies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 63 North America Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR %)
Figure 64 North America Drug Delivery Technologies Market Share Forecast by Route of Administration, 2024 & 2034 (%)
Figure 65 North America Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 66 North America Drug Delivery Technologies Market Share Forecast by Application, 2024 & 2034 (%)
Figure 67 North America Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 68 North America Drug Delivery Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 69 U.S. Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 70 Canada Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 71 Europe Drug Delivery Technologies Market Attractiveness Index
Figure 72 Europe Drug Delivery Technologies Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 73 Europe Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 74 Europe Drug Delivery Technologies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 75 Europe Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR %)
Figure 76 Europe Drug Delivery Technologies Market Share Forecast by Route of Administration, 2024 & 2034 (%)
Figure 77 Europe Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 78 Europe Drug Delivery Technologies Market Share Forecast by Application, 2024 & 2034 (%)
Figure 79 Europe Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 80 Europe Drug Delivery Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 81 Germany Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 82 UK Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 83 France Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 84 Italy Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 85 Spain Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 86 Russia Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 87 Rest of Europe Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 88 Asia Pacific Drug Delivery Technologies Market Attractiveness Index
Figure 89 Asia Pacific Drug Delivery Technologies Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 90 Asia Pacific Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 91 Asia Pacific Drug Delivery Technologies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 92 Asia Pacific Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR %)
Figure 93 Asia Pacific Drug Delivery Technologies Market Share Forecast by Route of Administration, 2024 & 2034 (%)
Figure 94 Asia Pacific Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 95 Asia Pacific Drug Delivery Technologies Market Share Forecast by Application, 2024 & 2034 (%)
Figure 96 Asia Pacific Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 97 Asia Pacific Drug Delivery Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 98 Japan Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 99 China Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 100 India Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 101 Australia Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 102 South Korea Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 103 South-East Asia Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 104 Rest of Asia Pacific Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 105 Latin America Drug Delivery Technologies Market Attractiveness Index
Figure 106 Latin America Drug Delivery Technologies Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 107 Latin America Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 108 Latin America Drug Delivery Technologies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 109 Latin America Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR %)
Figure 110 Latin America Drug Delivery Technologies Market Share Forecast by Route of Administration, 2024 & 2034 (%)
Figure 111 Latin America Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 112 Latin America Drug Delivery Technologies Market Share Forecast by Application, 2024 & 2034 (%)
Figure 113 Latin America Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 114 Latin America Drug Delivery Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 115 Brazil Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 116 Mexico Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 117 Rest of Latin America Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 118 MEA Drug Delivery Technologies Market Attractiveness Index
Figure 119 MEA Drug Delivery Technologies Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 120 MEA Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 121 MEA Drug Delivery Technologies Market Share Forecast by Country, 2024 & 2034 (%)
Figure 122 MEA Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR %)
Figure 123 MEA Drug Delivery Technologies Market Share Forecast by Route of Administration, 2024 & 2034 (%)
Figure 124 MEA Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 125 MEA Drug Delivery Technologies Market Share Forecast by Application, 2024 & 2034 (%)
Figure 126 MEA Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
Figure 127 MEA Drug Delivery Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
Figure 128 GCC Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 129 South Africa Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 130 Rest of MEA Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 131 Johnson & Johnson Services, Inc.: Net Revenue, 2015-2023 (US$ Million, AGR%)
Figure 132 Johnson & Johnson Services, Inc.: Regional Market Shares (%), 2023
Figure 133 Johnson & Johnson Services, Inc.: R&D, 2015-2023 (US$ Million, AGR%)
Figure 134 Novartis AG: Net Revenue, 2015-2023 (US$ Million, AGR%)
Figure 135 Novartis AG: Regional Market Shares (%), 2023
Figure 136 Novartis AG: R&D, 2015-2023 (US$ Million, AGR%)
Figure 137 F. Hoffmann-La Roche Ltd: Net Revenue, 2015-2023 (US$ Million, AGR%)
Figure 138 F. Hoffmann-La Roche Ltd: Regional Market Shares (%), 2023
Figure 139 F. Hoffmann-La Roche Ltd: R&D, 2015-2023 (US$ Million, AGR%)
Figure 140 Pfizer Inc.: Net Revenue, 2015-2023 (US$ Million, AGR%)
Figure 141 Pfizer Inc.: Regional Market Shares (%), 2023
Figure 142 Pfizer Inc.: R&D, 2015-2023 (US$ Million, AGR%)
Figure 143 Bayer AG: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 144 Bayer AG: Regional Market Shares (%), 2022
Figure 145 Bayer AG: R&D, 2015-2022 (US$ Million, AGR%)
Figure 146 Becton, Dickinson and Company: Net Revenue, 2015-2023 (US$ Million, AGR%)
Figure 147 Becton, Dickinson and Company: Regional Market Shares (%), 2023
Figure 148 Becton, Dickinson and Company: R&D, 2015-2023 (US$ Million, AGR%)
Figure 149 GSK plc: Net Revenue, 2015-2023 (US$ Million, AGR%)
Figure 150 GSK plc: Regional Market Shares (%), 2023
Figure 151 GSK plc: R&D, 2015-2023 (US$ Million, AGR%)
Figure 152 Merck & Co., Inc.: Net Revenue, 2015-2023 (US$ Million, AGR%)
Figure 153 Merck & Co., Inc.: Regional Market Shares (%), 2023
Figure 154 Merck & Co., Inc.: R&D, 2015-2023 (US$ Million, AGR%)
Figure 155 Sanofi: Net Revenue, 2015-2023 (US$ Million, AGR%)
Figure 156 Sanofi: Regional Market Shares (%), 2023
Figure 157 Sanofi: R&D, 2015-2023 (US$ Million, AGR%)
Figure 158 Amgen Inc.: Net Revenue, 2015-2023 (US$ Million, AGR%)
Figure 159 Amgen Inc.: R&D, 2015-2023 (US$ Million, AGR%)
Figure 160 Amgen Inc.: Regional Market Shares (%), 2023
Figure 161 AbbVie Inc.: Net Revenue, 2015-2023 (US$ Million, AGR%)
Figure 162 AbbVie Inc.: Regional Market Shares (%), 2023
Figure 163 AbbVie Inc.: R&D, 2015-2023 (US$ Million, AGR%)
Figure 164 Gilead Sciences, Inc.: Net Revenue, 2015-2023 (US$ Million, AGR%)
Figure 165 Gilead Sciences, Inc.: R&D, 2015-2023 (US$ Million, AGR%)
Figure 166 Boehringer Ingelheim: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 167 Boehringer Ingelheim: Regional Market Shares (%), 2022
Figure 168 AstraZeneca plc: Net Revenue, 2015-2023 (US$ Million, AGR%)
Figure 169 AstraZeneca plc: Regional Market Shares (%), 2023
Figure 170 AstraZeneca plc: R&D, 2015-2022 (US$ Million, AGR%)
Figure 171 Eli Lilly and Company: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 172 Eli Lilly and Company: Regional Market Shares (%), 2023
Figure 173 Eli Lilly and Company: R&D, 2015-2022 (US$ Million, AGR%)
Figure 174 Teva Pharmaceuticals Industries Ltd.: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 175 Teva Pharmaceuticals Industries Ltd.: Regional Market Shares (%), 2023
Figure 176 Teva Pharmaceuticals Industries Ltd.: R&D, 2015-2022 (US$ Million, AGR%)
Figure 177 Bristol-Myers Squibb: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 178 Bristol-Myers Squibb: Regional Market Shares (%), 2023
Figure 179 Bristol-Myers Squibb: R&D, 2015-2022 (US$ Million, AGR%)
Figure 180 Gerresheimer AG: Net Revenue, 2015-2023 (US$ Million, AGR%)
Figure 181 Gerresheimer AG: Regional Market Shares (%), 2023
Figure 182 Boston Scientific Corporation: Net Revenue, 2015-2022 (US$ Million, AGR%)
Figure 183 Boston Scientific Corporation: Regional Market Shares (%), 2023
Figure 184 Boston Scientific Corporation: R&D, 2015-2022 (US$ Million, AGR%)